Abstract: . . .  Panagiotis Tsirigotis, 1 George Mantzios, 1* Fotis Makris, 2 Yiannis Robos 1 Accepted 7 th September 2005 1 Hematology Department, Metropolitan Hospital, Piraeus, Greece. 2 Nephrology Department, Metropolitan Hospital, Piraeus, Greece. Panagiotis Tsirigotis, 1 MD, Consultant Hematologist. George Mantzios, 1* MD, Consultant Hematologist. Fotis Makris, 2 MD, Consultant Nephrologist. Yiannis Robos, 1 MD, Head of Hematology Department, Associated Professor of Medicine, National and Kapodistrian University of Athens, School of Medicine. Correspondence to : George Mantzios, MD, Alikarnassou 13, Vyronas, Athens, Greece, 162 33. E-mail: mantziosg@yahoo.gr surgical course was uneventful and the patient was discharged on the seventh post-operative day. Ten days after the surgical procedure and twelve days after the angiography, the patient was readmitted to our hospital because of an acute substernal pain with electrocardiogram findings suggestive of acute myocardial infarction. On clinical examination an intense oedema with pain and redness on her right . . .
. . .  Wien Klin Wochenschr 2000; 112(12): 552-5. 8. Whelen S, Carr ME Jr. Use of recombinant hirudin in heparin-induced thrombocytopenia and thrombosis (HITT) and renal failure: a case report. angiology 2001; 52(10): 711-5. 9. Nowak G, Bucha E, Brauns I, Czerwinski R. Anticoagulation with r- hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). The first long-term application of r-hirudin in a haemodialysis patient. Wien Klin Wochenschr 1997; 109(10): 354-8. 10. Fischer KG, van de Loo A, Bohler J. Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis. Kidney Int suppl 1999; (72): S46-50.  . . .
--2768,2,692,2320,13842